Attention deficit hyperactivity disorder in cocaine-dependent adults: A psychiatric comorbidity analysis

American Journal on Addictions

Volumn 22, Issue 5, 2013, Pages 466-473

  Daigre, Constanza ^a,b   Roncero, Carlos ^a,b   Grau López, Lara ^a,b   Martínez Luna, Nieves ^a,b   Prat, Gemma ^c   Valero, Sergi ^a   Tejedor, Rosa ^c   Ramos Quiroga, Josep A ^a   Casas, Miguel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Althaia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIVARIATE ANALYSIS; CANNABIS ADDICTION; CLINICAL EVALUATION; COCAINE DEPENDENCE; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DESCRIPTIVE RESEARCH; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; ONSET AGE; RISK FACTOR; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COCAINE-RELATED DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMPLOYMENT; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MARIJUANA ABUSE; MULTIVARIATE ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84882589457     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12047.x     Document Type: Article

References (55)

1. European Monitoring Centre for Drugs and Drug addiction (EMCDDA). Annual Report 2009: The State of the Drugs Problem in Europe. Lisbon: EMCDDA; 2009.
2. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62: 617-627.
3. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007; 190: 402-409.
4. Clure C, Brady KT, Saladin ME, et al. Attention-deficit/hyperactivity disorder and substance use: Symptom pattern and drug choice. Am J Drug Alcohol Abuse. 1999; 25: 441-448.
5. Wilens TE, Dodson W., A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry. 2004; 65: 1301-1313.
6. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163: 716-723.
7. Arias AJ, Gelernter J, Chan G, et al. Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 2008; 33: 1199-1207.
8. Daigre Blanco C, Ramos-Quiroga JA, Valero S, et al. Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2009; 37: 299-305.
9. Perez de Los Cobos J, Sinol N, Puerta C, et al. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders. Psychiatry Res. 2010; 30: 205-210.
10. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993; 150: 1792-1798.
11. Barkley RA., Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002; 63: 10-15.
12. Fischer M, Barkley RA, Smallish L, et al. Young adult follow-up of hyperactive children: Self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol. 2002; 30: 463-475.
13. Harwood HJ, Myers TG., eds. New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Washington, DC: National Academy of Sciences; 2004.
14. Able SL, Johnston JA, Adler LA, et al. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med. 2007; 37: 97-107.
15. Bernfort L, Nordfeldt S, Persson J., ADHD from a socio-economic perspective. Acta Paediatr. 2008; 97: 239-245.
16. Goksøyr PK, Nøttestad JA., The burden of untreated ADHD among adults: The role of stimulant medication. Addict Behav. 2008; 33: 342-346.
17. Carroll KM, Rounsaville BJ., History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry. 1993; 34: 75-82.
18. Wilens TE, Biederman J, Mick E, et al. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis. 1997; 185: 475-482.
19. Biederman J, Wilens TE, Mick E, et al. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence ? Biol Psychiatry. 1998; 44: 269-273.
20. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000; 61: 244-251.
21. Levin FR, Evans SM, Kleber HD., Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998; 52: 15-25.
22. Biederman J, Wilens T, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry. 1995; 152: 1652-1658.
23. Milberger S, Biederman J, Faraone SV, et al. Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict. 1997; 6: 318-329.
24. Flory K, Milich R, Lynam DR, et al. Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: Individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav. 2003; 17: 151-158.
25. Marshal MP, Molina BS., Antisocial behaviors moderate the deviant peer pathway to substance use in children with ADHD. J Clin Child Adolesc Psychol. 2006; 35: 216-226.
26. Brook DW, Brook JS, Zhang C, et al. Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch Pediatr Adolesc Med. 2010; 164: 930-934.
27. Fergusson DM, Horwood LJ, Ridder EM., Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: Results of a 25-year longitudinal study. Drug Alcohol Depend. 2007; 88: S14-S26.
28. Biederman J, Petty CR, Wilens TE, et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2008; 165: 107-115.
29. Volkow ND, Fowler JS, Wang GJ, et al. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol Psychiatry. 2004; 9: 557-569.
30. Volkow ND, Wang GJ, Kollins SH, et al. Evaluating dopamine reward pathway in ADHD: Clinical implications. JAMA. 2009; 302: 1084-1091.
31. Brook JS, Brook DW, Gordon AS, et al. The psychosocial etiology of adolescent drug use: A family interactional approach. Genet Soc Gen Psychol Monogr. 1990; 116: 111-267.
32. Khantzian EJ., The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry. 1997; 4: 231-244.
33. Kalbag AS, Levin FR., Adult ADHD and substance abuse: Diagnostic and treatment issues. Subst Use Misuse. 2005; 40: 1955-1981.
34. Bange F., Attention deficit hyperactivity disorder outcome in adults. Arch Pediatr. 2011; 18: 831-834.
35. Epstien J, Johonson D, Conners CK., eds. Conners Adult ADHS Diagnostic Interview for DSM IV. Multi-Health Systems ed. North Tonawanda, NY: Conners; 1999.
36. Ramos-Quiroga JA, Bosch R, Richarte V, et al. Criterion and concurrent validity of Conners adult ADHD diagnostic interview for DSM-IV (CAADID) Spanish version. Revista De Psiquiatria y Salud Mental. 2012; 5: 229-235.
37. Bobes J, Bascarán M, Bobes T, et al. Valoración de la gravedad de la adicción: Aplicación a la gestión y monitorización de los tratamientos. Madrid: Ministerio de Sanidad y Política Social, Madrid; 2007.
38. Sanchez-Hervas E, Secades-Villa R, Jose Santonja Gomez F, et al. Addictive severity in cocaine addicts measured with the EuropASI: Differences between composite scores and severity ratings. Am J Addict. 2009; 18: 375-378.
39. József R, Csilla P, Nauszika MA., The reliability and validity testing of the Hungarian version of the EuropASI. Magyar Psichologiai Szemle. 2002; 57: 587-603.
40. Sheurich A, Muller MJ, Wetzel H, et al. Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol. 2000; 61: 916-919.
41. Spitzer R, Robert L, Gibbon M., SCID-I, Version clínica, entrevista clínica estructurada para los trastornos del eje I del DSM. Barcelona: Masson; 1996.
42. Segal DL, Hersen M, Van Hasselt VB., Reliability of the Structured Clinical Interview for DSM-III-R: An evaluative review. Compr Psychiatry. 1994; 35: 316-327.
43. First M, Gibbon M, Spitzer R., SCID-II, Entrevista Clínica Estructurada para los trastornos de personalidad del Eje II del DSM-IV. Barcelona: Masson; 2003.
44. Malow R, West J, Williams J., Personality disorders classifications and symptoms in cocaine and opioid addicts. J Consult Clin Psychol. 1989; 57: 765-767.
45. Biederman J, Mick E, Faraone SV., Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry. 2000; 157: 816-818.
46. Kollins SH., ADHD, substance use disorders, and psychostimulant treatment: Current literature and treatment guidelines. J Atten Disord. 2008; 11: 115-125.
47. Fergusson DM, Boden JM., Cannabis use and adult ADHD symptoms. Drug Alcohol Depend. 2008; 1: 90-96.
48. Aharonovich E, Garawi F, Bisaga A, et al. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: Effects on outcome. Am J Drug Alcohol Abuse. 2006; 32: 629-635.
49. Disney ER, Elkins IJ, McGue M, et al. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999; 156: 1515-1521.
50. Flory K, Lynam DR., The relation between attention deficit hyperactivity disorder and substance abuse: What role does conduct disorder play ? Clin Child Fam Psychol Rev. 2003; 6: 1-16.
51. Carpentier PJ, van Gogh MT, Knapen LJ, et al. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res. 2010; 17: 10-20.
52. Simon V, Czobor P, Balint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. Br J Psychiatry. 2009; 194: 204-211.
53. Ramos-Quiroga JA, Bosch-Munso R, Castells-Cervello X, et al. Attention deficit hyperactivity disorder in adults: A clinical and therapeutic characterization. Rev Neurol. 2006; 16: 600-606.
54. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: Findings from multiplex families. Am J Psychiatry. 2005; 162: 1621-1627.
55. Levin FR, Bisaga A, Raby W, et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. J Subst Abuse Treat. 2008; 34: 80-89.